Quantcast

Latest Thiols Stories

2010-10-15 01:19:15

Researchers have developed a method for curbing the growth of crystals that form cystine kidney stones. Their findings, which appear in the latest issue of the journal Science, may offer a pathway to a new method for the prevention of kidney stones. The study was conducted by researchers at New York University's Department of Chemistry and its Molecular Design Institute, NYU School of Medicine, and the Medical College of Wisconsin. Kidney stones comprised of L-cystine affect at least 20,000...

2010-09-13 10:15:00

NASHVILLE, Tenn., Sept. 13 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the UBS Global Life Sciences Conference at the Grand Hyatt New York on Monday, September 20, 2010, at 12:00 p.m. Eastern Time. The presentation will be simultaneously webcast and can be accessed by visiting the Investor Relations...

2010-08-02 12:12:00

NASHVILLE, Tenn., Aug. 2 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference at the Southampton Inn in Southampton, New York on Friday, August 13, 2010 at 9:20 a.m. Eastern Time. The presentation will be simultaneously webcast and can be...

2010-06-03 15:05:00

NASHVILLE, Tenn., June 3 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Chief Executive Officer A.J. Kazimi will present a corporate overview at the Wells Fargo Healthcare Conference in Boston at 9:30 a.m. Eastern Time on Wednesday, June 23, 2010. The presentation will be simultaneously webcast and can be accessed by visiting the Investor...

2010-05-20 14:59:00

NASHVILLE, Tenn., May 20 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Chief Commercial Officer Martin E. Cearnal will present a corporate overview at the Jefferies Global Life Sciences Conference in New York at 11:30 a.m. Eastern Time on Tuesday, June 8, 2010. The presentation will be simultaneously webcast and can be accessed by visiting the...

2010-02-10 07:00:00

NOVATO, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), today announced the presentation of cystinosis data at the Annual Lysosomal Disease Network WORLD Symposium 2010, being held February 10-12 in Miami, Florida. Biomarker data from a Phase IIb pilot study of Raptor's proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") will be the subject of a poster titled, "Correlation of Plasma Cysteamine and WBC Cystine...

2010-02-04 23:21:02

First study to demonstrate association between asthma and acetaminophen is linked to gene involved in detoxification of foreign substances Children who were exposed to acetaminophen prenatally were more likely to have asthma symptoms at age five in a study of 300 African-American and Dominican Republic children living in New York City. Building on prior research showing an association between both prenatal and postnatal acetaminophen and asthma, this is the first study to demonstrate a direct...

2010-01-11 05:30:00

NOVATO, Calif., Jan. 11 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), today announced the publication of results from a Phase 2a clinical trial of a prototype formulation of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis"). Ranjan Dohil, M.D., Professor of Pediatrics at the University of California, San Diego, was lead author of the study to be published in...

2010-01-04 14:28:06

Johns Hopkins University researchers have created biodegradable nanosized particles that can easily slip through the body's sticky and viscous mucus secretions to deliver a sustained-release medication cargo. The researchers say these nanoparticles, which degrade over time into harmless components, could one day carry life-saving drugs to patients suffering from dozens of health conditions, including diseases of the eye, lung, gut or female reproductive tract. The mucus-penetrating...

2009-12-10 10:09:00

RALEIGH, N.C., Dec. 10 /PRNewswire/ -- Ajinomoto announced today a new initiative to develop propriety fermentation technology for producing cystine and cysteine, amino acids important in a wide array of applications, including pharmaceuticals, flavorings, and cosmetics. Ajinomoto's expansion in this marketplace will offer additional sourcing options for manufacturers, as it will make available cystine and cysteine that are produced by microbial fermentation of starches and/or sugars....


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.